SP07 | EFFICACY AND TOLERABILITY OF THE IBRUTINIB-VENETOCLAX COMBINATION IN THE TREATMENT OF ATYPICAL CHRONIC LYMPHOCYTIC LEUKEMIA: A MONOCENTRIC CLINICAL EXPERIENCE

Introduction: CLL is a heterogeneous B-cell malignancy with a range of clinical and molecular features. aCLL represents an unmet clinical need because it is characterized by unconventional features (e.g. lack of CD23 expression, evidence of BCL1 rearrangement) with a poor response to classical trea...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	G. Farina, M. Di Palma, A. D'ambrosio, G. Cetani, G. Monaco, M. Troiano, E. Vatiero, M. Iovine, S. Iaccarino, F. Frigeri.
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-09-01
Online Access:	https://haematologica.org/article/view/12327